Bcel stock forecast.

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cheniere Energy share forecasts, stock quote and buy / sell signals below. According to present data Cheniere Energy's LNG shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).

Bcel stock forecast. Things To Know About Bcel stock forecast.

View Tecnoglass Inc TGLS investment & stock information. Get the latest Tecnoglass Inc TGLS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Gas prices are at a record high, and experts are forecasting that prices could go higher this summer — perhaps $5 or even over $6 a gallon. By clicking "TRY IT", I agree to receive newsletters and promotions from Money and its partners. I a...According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.Atreca, Inc. Class A Common Stock (BCEL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.BCEL Stock Analysis Overview What this means: InvestorsObserver gives Atreca Inc Cl A (BCEL) an overall rank of 35, which is below average. Atreca Inc Cl A is in the bottom …

The average Adma Biologics stock price prediction forecasts a potential upside of 43.11% from the current ADMA share price of $3.96. What is ADMA's forecast return on equity (ROE) for 2023-2026? (NASDAQ: ADMA) forecast ROE is N/A, which is considered weak.Find the latest Atreca, Inc. (BCEL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Atreca Inc (NASDAQ:BCEL) 0.2302. Delayed Data. As of Nov 30. +0.0047 / +2.19%. Today’s Change. 0.19. Today ||| 52-Week Range. 2.05.Atreca Stock Forecast and Price Target. According to six esteemed experts, the average price target for Atreca to reach this year is $17.00, with a potential upside of …

Atreca Inc (BCEL) Stock Price & News - Google Finance Home BCEL • NASDAQ Atreca Inc Follow Share $0.21 After Hours: $0.22 (2.90%) +0.0062 Closed: Nov 24, 3:00:17 PM GMT-5 · USD · NASDAQ ·... Nasdaq +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Atreca, Inc. (BCEL) NasdaqGS - NasdaqGS Real Time Price. Currency in USD... Shares of Atreca, Inc. (. BCEL Quick Quote. BCEL - Free Report) have been struggling lately and have lost 20% over the past week. However, a hammer chart pattern was formed in its last trading ...Analyst Forecast. According to 5 analysts, the average rating for BCEL stock is "Hold." The 12-month stock price forecast is $3.38, which is an increase of …Find real-time NU - Nu Holdings Ltd stock quotes, company profile, news and forecasts from CNN Business.

The latest Atreca stock prices, stock quotes, news, and BCEL history to help you invest and trade smarter. ... The 11 analysts offering price forecasts for Atreca have a median target of 11.77 ...

Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...

Find real-time NU - Nu Holdings Ltd stock quotes, company profile, news and forecasts from CNN Business.$0.22 USD +0.01 (2.90%) Updated Nov 27, 2023 11:22 AM ET Add to portfolio Zacks Rank: 3-Hold 3 Style Scores: F Value | A Growth | C Momentum | C VGM Industry …On May 10, 2023, Atreca (NASDAQ:BCEL) announced its financial results for the first quarter of the year. The company reported Atreca Reports Q1 2023 Financial Results with Exceeding Analyst Estimates - Best StocksAverage. $3.25. Current Price. $0.21. Options. Overview. Research & Ratings. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume ...See Atreca, Inc. (BCEL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Viking Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Viking Therapeutics's VKTX shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).

The current Atreca [ BCEL] share price is $0.21. The Score for BCEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. BCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.Zacks News for BCEL Atreca (BCEL) Suspends Lead Drug Evaluation, Stock Falls 37% 08/14/23-9:51AM EST Zacks Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now 04/06/23-8:55AM EST ...Atreca is forecast to grow earnings and revenue by 10.3% and 9.5% per annum respectively while EPS is expected to grow by 30.2% per annum.Explore Atreca, Inc. (BCEL) earnings date, Atreca, Inc. stock earnings history, EPS, estimated EPS, earnings-related price changes, and more.Nov 29, 2023 · Based on short-term price targets offered by four analysts, the average price target for Atreca, Inc. comes to $5.25. The forecasts range from a low of $1.00 to a high of $10.00. The average price ...

Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...

How much is Atreca stock worth today? ( NASDAQ: BCEL) Atreca currently has 39,295,661 outstanding shares. With Atreca stock trading at $0.27 per share, the total value of Atreca stock (market capitalization) is $10.41M. Atreca stock was originally listed at a price of $18.05 in Jun 20, 2019.BCEL Overview Stock Screener Earnings Calendar Sectors Nasdaq | BCEL U.S.: Nasdaq Atreca Inc. Cl A Watch Set a price target alert After Hours Last Updated: Nov 17, 2023 …ATRECA, INC. stock price forecast for further price development down to -100.00% (time horizon: 1 day) and price target of 0.00 USD. Negative news sentiment. Short-term (time horizon: 2 weeks) ATRECA, INC. share price prediction for 2024-01-12 with daily closed price projectionsHere's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now Zacks - Thu Apr 6, 8:55AM CDT . Atreca, Inc. (BCEL) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall...Find the latest Atreca, Inc. (BCEL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.$191.45 +1.76 +0.93% Find the latest analyst research for Atreca, Inc. Class A Common Stock (BCEL) at Nasdaq.com.The average Adma Biologics stock price prediction forecasts a potential upside of 43.11% from the current ADMA share price of $3.96. What is ADMA's forecast return on equity (ROE) for 2023-2026? (NASDAQ: ADMA) forecast ROE is N/A, which is considered weak.

Explore Atreca, Inc. (BCEL) earnings date, Atreca, Inc. stock earnings history, EPS, estimated EPS, earnings-related price changes, and more.

The 360 Finance, Inc. stock price fell by -2.78% on the last day (Wednesday, 22nd Nov 2023) from $16.53 to $16.07. During the last trading day the stock fluctuated 4.68% from a day low at $15.81 to a day high of $16.55. The price has risen in 6 of the last 10 days and is up by 4.15% over the past 2 weeks.

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cheniere Energy share forecasts, stock quote and buy / sell signals below. According to present data Cheniere Energy's LNG shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).BCEL reported Q4'22 and full year earnings on March 29. Cash, cash equivalents and investments were $70.5M at the end of 2022. R&D expenses were $66.8M for 2022 and G&A expenses were $31.5M for ...Learn more about Atreca Inc's (BCEL) stock grades for Momentum, Growth and Estimate Revisions and determine whether this Biotechnology & Medical Research stock meets your investment needs. ... The Biotechnology and Medical Research sub-industry has a positive outlook, a historically defensive sub-industry. Drug sales are …View SilverBow Resources SBOW investment & stock information. Get the latest SilverBow Resources SBOW detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Earnings announcement* for BCEL: Our vendor, Zacks Investment Research, hasn't provided us with the upcoming earnings report date. BCEL has a "high" Earnings Quality Ranking (EQR) for the 5th ... See Atreca, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... The 4 analysts offering 1 year price forecasts for BCEL have a max estimate of — …Forecst.com predicts future values using technical analysis of a large number of analytical parameters. BCLI stock returns are also predicted based on historical data. According to our research, BCLI stock is a bad long-term investment. BCLI share price has been in a bear cycle for the past year.Based on analysts offering 12 month price targets for BCEL in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . $0.22 USD +0.01 (2.90%) Updated Nov 27, 2023 11:22 AM ET Add to portfolio Zacks Rank: 3-Hold 3 Style Scores: F Value | A Growth | C Momentum | C VGM Industry …Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at data ...

Detailed statistics for Atreca, Inc. (BCEL) stock, including valuation metrics, financial numbers, share information and more. Detailed statistics for Atreca, Inc. (BCEL) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The average price target for Atreca is $3.38, which is 1,415.70% ...The latest Atreca stock prices, stock quotes, news, and BCEL history to help you invest and trade smarter. ... The 11 analysts offering price forecasts for Atreca have a median target of 11.77 ...W & T Offshore Inc () Stock Market info Recommendations: Buy or sell W & T Offshore stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the W & T Offshore share forecasts, stock quote and buy / sell signals below.According to present data W & T Offshore's WTI shares and potentially its market environment have been in …Explore BCEL - Atreca Inc Stock Price Forecast: Accurate short-term and long-term price predictions up to 2050Instagram:https://instagram. brokers with no options feesshaquille o'neal shoes at walmartbest brokerage to trade optionshigh yield brokerage account Nov 23, 2023 · Science. Atreca Inc (NASDAQ:BCEL)’s traded shares stood at 0.33 million during the last session, with the company’s beta value hitting 1.24. At the close of trading, the stock’s price was $0.21. The BCEL share’s 52-week high remains $2.05, putting it -876.19% down since that peak but still an impressive 9.52% since price per share fell ... arrived investing reviewsproperties investment company Cymabay Therapeutics Inc () Stock Market info Recommendations: Buy or sell Cymabay Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cymabay Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Cymabay Therapeutics's CBAY shares and potentially …Find the latest Atreca, Inc. (BCEL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. orcl ticker Atreca, Inc. Class A Common Stock (BCEL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Forecst.com predicts future values using technical analysis of a large number of analytical parameters. BCLI stock returns are also predicted based on historical data. According to our research, BCLI stock is a bad long-term investment. BCLI share price has been in a bear cycle for the past year.